Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-26

Clinical Trial Update: Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis [NA]

View source ↗

Summary

A completed clinical trial evaluating urine trypsinogen 2 dipstick for early detection of post-ERCP pancreatitis; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Indiana University | Conditions: Post-ERCP Acute Pancreatitis | NA | Status: COMPLETED | Results posted: 2023-06-26